We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Avidity Biosciences Inc | NASDAQ:RNA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.705 | 2.76% | 26.285 | 26.26 | 26.32 | 27.34 | 26.075 | 26.68 | 337,314 | 18:30:13 |
☐
|
Rule 13d-1(b) |
☐
|
Rule 13d-1(c) |
ý
|
Rule 13d-1(d) |
1. |
Names of Reporting Persons
Eli Lilly and Company
|
||||
2. |
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ☐
(b) ☐
|
||||
3. |
SEC Use Only
|
||||
4. |
Citizenship or Place of Organization
Indiana
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
WITH |
5. |
Sole Voting Power
2,319,396
|
||||||
6. |
Shared Voting Power
0
|
|||||||
7. |
Sole Dispositive Power
2,319,396
|
|||||||
8. |
Shared Dispositive Power
0
|
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
2,319,396
|
||||
10. |
Check Box if the Aggregate Amount in Row 9 Excludes Certain Shares (See
Instructions)
☐
|
||||
11. |
Percent of Class Represented by Amount in Row (9)
6.2%(1)
|
||||
12. |
Type of Reporting Person (See Instructions)
CO
|
Item 1. | Name of Issuer |
(a) | Name of Issuer: | ||||
Avidity Biosciences, Inc.
|
|||||
(b) | Address of Issuer’s Principal Executive Offices: | ||||
10975 N. Torrey Pines Rd., Suite #150 | |||||
La Jolla, CA 92037 |
Item 2. | Name of Person Filing |
(a) | Name: | ||||
Eli Lilly and Company |
(b) | Address of Principal Business Office: | ||||
c/o Lilly Corporate Center | |||||
Indianapolis, Indiana 46285 |
(c) | Citizenship: | ||||
Indiana corporation |
(d) | Title of Class of Securities: | ||||
Common Stock, $0.0001 par value
|
(e) | CUSIP Number: | ||||
05370A108
|
Item 3. | If this statement is filed pursuant to § 240.13d-1(b) or § 240.13d-2(b) or (c), check whether the person filing is a: | ||||
Not applicable. |
Item 4. | Ownership. |
All ownership information is as of December 31, 2020. |
(a) | Amount Beneficially Owned: See Item 9 of Cover Sheet. |
(b) | Percent of Class: See Item 11 of Cover Sheet. |
(c) | Number of shares as to which the person has: |
(i) | sole power to vote of to direct the vote: See Item 5 of Cover Sheet. |
(ii) | shared power to vote or to direct the vote: See Item 6 of Cover Sheet. |
(iii) | sole power to dispose or to direct the disposition of: See Item 7 of Cover Sheet. |
(iv) | shared power to dispose or to direct the disposition of: See Item 8 of Cover Sheet. |
Item 5. | Ownership of Five Percent or Less of a Class | ||||
Not Applicable. |
Item 6. | Ownership of More than Five Percent on Behalf of Another Person | ||||
Not Applicable. |
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company | ||||
Not Applicable. |
Item 8. | Identification and Classification of Member of the Group | ||||
Not Applicable.
|
Item 9. | Notice of Dissolution of Group | ||||
Not Applicable. |
Item 10. | Certification | ||||
Not Applicable. |
Dated: February 12, 2021 | By: | * | |||||||||
Authorized Signatory | |||||||||||
/s/ Erin Conway | |||||
*By: | Erin Conway | ||||
Attorney-in-Fact |
1 Year Avidity Biosciences Chart |
1 Month Avidity Biosciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions